Namik Kemal Universitesi Sagli Uygulama ve Arastirma Hastanesi

Süleymanpa?a 59100

0 studies enrolling now · 1 studies all time

What they study most

Primary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis

Studies at this site

• A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis — Completed